CAR-T THERAPIES
Reprogram the immune system to attack cancer with precision.
What are they?
An immunotherapy that uses the patient's own T cells: they are collected, genetically modified to recognize specific cancer cells, and reinfused, where they multiply and destroy them.
Why they work
Thanks to personalized chimeric receptors, they identify molecules on tumor cells and minimize damage to healthy cells. They have achieved high remission rates in advanced or refractory hematological cancers.
Second line of treatment
They are becoming established as a second-line treatment for diffuse large B-cell lymphoma and acute lymphoblastic leukemia in patients who do not respond to initial therapies. The remaining challenge is making them accessible.
POTENTIAL
Beyond hematology.
The scope of CAR-T therapy extends beyond blood cancers. Research is underway in solid tumors, infectious diseases, autoimmune disorders, and genetic conditions, leveraging its ability to redirect and modulate the immune system.